128 related articles for article (PubMed ID: 31675124)
1. Immunopharmacological effect of β-d-mannuronic acid (M2000), as a new immunosuppressive drug, on gene expression of miR-155 and its target molecules (SOCS1, SHIP1) in a clinical trial on rheumatoid arthritis patients.
Mortazavi-Jahromi SS; Aslani M; Omidian S; Ahmadzadeh A; Rezaieyazdi Z; Mirshafiey A
Drug Dev Res; 2020 May; 81(3):295-304. PubMed ID: 31675124
[TBL] [Abstract][Full Text] [Related]
2. The role of β-d-mannuronic acid, as a new non-steroidal anti-inflammatory drug on expression of miR-146a, IRAK1, TRAF6, NF-κB and pro-inflammatory cytokines following a clinical trial in rheumatoid arthritis patients.
Mortazavi-Jahromi SS; Ahmadzadeh A; Rezaieyazdi Z; Aslani M; Omidian S; Mirshafiey A
Immunopharmacol Immunotoxicol; 2020 Jun; 42(3):228-236. PubMed ID: 32223462
[No Abstract] [Full Text] [Related]
3. Evaluation of the Effect of Mannuronic Acid as a Novel NSAID With Immunosuppressive Properties on Expression of SOCS1, SOCS3, SHIP1, and TRAF6 Genes and Serum Levels of IL-6 and TNF-α in Patients With Multiple Sclerosis.
Najafi S; Saadat P; Beladi Moghadam N; Manoucherinia A; Aghazadeh Z; Vali Mohammadi A; Pashaiefar H; Hosseini M; Mirshafiey A
J Clin Pharmacol; 2021 Oct; 61(10):1303-1310. PubMed ID: 33908653
[TBL] [Abstract][Full Text] [Related]
4. The Oral Administration Effect of Drug Mannuronic Acid (M2000) on Gene Expression of Matrix and Tissue Inhibitor of Metalloproteinases in Rheumatoid Arthritis Patients.
Gaafar NAG; Aslani M; Aghazadeh Z; Razavi A; Mirshafiey A
Curr Drug Discov Technol; 2020; 17(5):704-710. PubMed ID: 31250758
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological effects of β-d-mannuronic acid (M2000) on miR-146a, IRAK1, TRAF6 and NF-κB gene expression, as target molecules in inflammatory reactions.
Mortazavi-Jahromi SS; Jamshidi MM; Farazmand A; Aghazadeh Z; Yousefi M; Mirshafiey A
Pharmacol Rep; 2017 Jun; 69(3):479-484. PubMed ID: 28324845
[TBL] [Abstract][Full Text] [Related]
6. The Situation of Chemokine Ligands and Receptors Gene Expression, Following the Oral Administration of Drug Mannuronic Acid in Rheumatoid Arthritis Patients.
Aslani M; Ahmadzadeh A; Rezaieyazdi Z; Mortazavi-Jahromi SS; Barati A; Hosseini M; Mirshafiey A
Recent Pat Inflamm Allergy Drug Discov; 2020; 14(1):69-77. PubMed ID: 31729947
[TBL] [Abstract][Full Text] [Related]
7. Effects of guluronic acid (G2013) on SHIP1, SOCS1 induction and related molecules in TLR4 signaling pathway.
Mortazavi-Jahromi SS; Farazmand A; Motamed N; Navabi SS; Mirshafiey A
Int Immunopharmacol; 2018 Feb; 55():323-329. PubMed ID: 29310108
[TBL] [Abstract][Full Text] [Related]
8. Effects of β-d-mannuronic acid, as a novel non-steroidal anti-inflammatory medication within immunosuppressive properties, on
Barati A; Jamshidi AR; Ahmadi H; Aghazadeh Z; Mirshafiey A
Drug Des Devel Ther; 2017; 11():1027-1033. PubMed ID: 28408801
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of β-D-Mannuronic Acid [M2000] on the Pro-Apoptotic Process and Inflammatory-Related Molecules NFκB, IL-8 and Cd49d using Healthy Donor PBMC.
Khalatbari A; Mahdavi M; Jafarnezhad F; Afraei S; Zavareh FT; Aghazadeh Z; Ghaderi A; Mirshafiey A
Curr Drug Discov Technol; 2020; 17(2):225-232. PubMed ID: 30417790
[TBL] [Abstract][Full Text] [Related]
10. Hematological Improvement of Patients with Active Rheumatoid Arthritis by β-D-Mannuronic Acid (M2000) as a Novel NSAID with Immunosuppressive Property.
Ahmadi H; Jamshidi AR; Mahmoudi M; Gharibdoost F; Vojdanian M; Fattahi MJ; Rastkari N; Aghazadeh Z; Mirshafiey A
Iran J Allergy Asthma Immunol; 2017 Oct; 16(5):433-442. PubMed ID: 29149783
[TBL] [Abstract][Full Text] [Related]
11. Effects of mannuronic acid (M2000) on gene expression profile of signal transducer and activator of transcription proteins (STATs) in rheumatoid arthritis patients.
Gaafar NAG; Aslani M; Aghazadeh Z; Mortazavi-Jahromi SS; Razavi A; Mirshafiey A
Reumatismo; 2020 Jul; 72(2):93-102. PubMed ID: 32700875
[TBL] [Abstract][Full Text] [Related]
12. Evaluating Mannuronic Acid Effect on Gene Expression Profile of Inflammatory Mediators in Rheumatoid Arthritis Patients.
Omidian S; Aghazadeh Z; Ahmadzadeh A; Aslani M; Hosseini M; Abbasi S; Mirshafiey A
Iran J Allergy Asthma Immunol; 2022 Feb; 21(1):44-54. PubMed ID: 35524377
[TBL] [Abstract][Full Text] [Related]
13. The Anti-Migraine Effects of M2000 (β-D-Mannuronic Acid) on a Patient with Rheumatoid Arthritis: Case Report.
Vojdanian M; Ahmadi H; Jamshidi AR; Mahmoudi M; Gharibdoost F; Barati A; Mirshafiey A
Curr Clin Pharmacol; 2017; 12(2):127-130. PubMed ID: 28578645
[TBL] [Abstract][Full Text] [Related]
14. The Potent Inhibitory Effect of β-D-Mannuronic Acid (M2000) as a Novel NSAID with Immunosuppressive Property on Anti-Cyclic Citrullinated Peptide Antibodies, Rheumatoid Factor and Anti-dsDNA Antibodies in Patients with Rheumatoid Arthritis.
Ahmadi H; Jamshidi AR; Mahmoudi M; Cuzzocrea S; Fattahi MJ; Barati A; Rehm BHA; Matsuo H; Mirshafiey A
Curr Drug Discov Technol; 2017; 14(3):206-214. PubMed ID: 28325148
[TBL] [Abstract][Full Text] [Related]
15. Modification of Sexual Hormones in Rheumatoid Arthritis Patients by M2000 (β-D-mannuronic Acid) as a Novel NSAID with Immunosuppressive Property.
Jahanbakhshi M; Babaloo Z; Mortazavi-Jahromi SS; Shokri MM; Ahmadi H; Mirshafiey A
Endocr Metab Immune Disord Drug Targets; 2018; 18(5):530-536. PubMed ID: 29667557
[TBL] [Abstract][Full Text] [Related]
16. The Role of M2000 as an Anti-inflammatory Agent in Toll-Like Receptor 2/microRNA-155 Pathway.
Pourgholi F; Hajivalili M; Razavi R; Esmaeili S; Baradaran B; Movasaghpour AA; Sadreddini S; Goodarzynejad H; Mirshafiey A; Yousefi M
Avicenna J Med Biotechnol; 2017; 9(1):8-12. PubMed ID: 28090274
[TBL] [Abstract][Full Text] [Related]
17. A phase I/II randomized, controlled, clinical trial for assessment of the efficacy and safety of β-D-mannuronic acid in rheumatoid arthritis patients.
Ahmadi H; Jamshidi AR; Gharibdoost F; Mahmoudi M; Rastkari N; Mostafaei S; Fattahi MJ; Vojdanian M; Cuzzocrea S; Rehm BHA; Matsuo H; Hosseini M; Aghazadeh Z; Mortazavi-Jahromi SS; Mirshafiey A
Inflammopharmacology; 2018 Jun; 26(3):737-745. PubMed ID: 29696564
[TBL] [Abstract][Full Text] [Related]
18. Influence of β-D-mannuronic Acid, as a New Member of Non-steroidal Anti- Inflammatory Drugs Family, on the Expression Pattern of Chemokines and their Receptors in Rheumatoid Arthritis.
Aslani M; Ahmadzadeh A; Aghazadeh Z; Zaki-Dizaji M; Sharifi L; Hosseini M; Mirshafiey A
Curr Drug Discov Technol; 2021; 18(1):65-74. PubMed ID: 31657689
[TBL] [Abstract][Full Text] [Related]
19. Targeting of circulating Th17 cells by β-D-mannuronic acid (M2000) as a novel medication in patients with rheumatoid arthritis.
Ahmadi H; Mahmoudi M; Gharibdoost F; Vojdanian M; Jamshidi AR; Fattahi MJ; Aghazadeh Z; Barati A; Mirshafiey A
Inflammopharmacology; 2018 Feb; 26(1):57-65. PubMed ID: 29063487
[TBL] [Abstract][Full Text] [Related]
20. The potent suppressive effect of β-d-mannuronic acid (M2000) on molecular expression of the TLR/NF-kB Signaling Pathway in ankylosing spondylitis patients.
Roozbehkia M; Mahmoudi M; Aletaha S; Rezaei N; Fattahi MJ; Jafarnezhad-Ansariha F; Barati A; Mirshafiey A
Int Immunopharmacol; 2017 Nov; 52():191-196. PubMed ID: 28938189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
